FDA scientists consider HIV treatment safe as first-line treatment
WASHINGTON A drug made by Pfizer for treating HIV is safe for patients who have not taken other drugs, according to briefing documents posted online Tuesday by the Food and Drug Administration.
Scientists at the FDA appear to favor approval for the new use of Selzentry (maraviroc), currently approved as a second-line treatment for HIV patients.
On Thursday, the briefing information will go before the FDA’s Antiviral Drugs Advisory Committee, which will decide whether or not to recommend approval. Advisory committees’ recommendations do not guarantee approval or rejection of a regulatory application, but they are taken into consideration when the FDA makes its final decision.
A&P teams up with ESI Medical to implement flu shot program
MONTVALE, N.J. A&P’s family of supermarkets is gearing up for the cold and flu season with a new flu vaccine program that enables shoppers to obtain free and discounted seasonal and H1N1 (when available) flu vaccinations.
A&P has teamed up with ESI Medical for the implementation of a serious of multi-state flu vaccination clinics that will run now through Dec. 23. In total, A&P will host more than 600 flu vaccination clinics, offering seasonal and H1N1 (when available) flu vaccinations in 250 stores throughout six states. Clinic locations can be found at www.getmyflushot.com.
In addition, the retailer has announced a “buy one get one free” flu shot offer. Through this new campaign, customers who use their Club Card through Oct. 29 and spend $100 on health and beauty care products (excluding baby items) will receive a Wellness Reward Certificate good for one free flu vaccination upon the purchase of accompanying flu shot at $30. Any A&P shopper receiving a flu shot at an in-store clinic will receive a coupon book with savings on hundreds of cough, cold/flu, grocery, non-foods and health items.
CRN launches collaborative program to educate consumers on dietary supplements
NEW YORK The most significant piece of news to come out of this (outside of the fact that CRN’s popular “Life…supplemented” campaign will continue) is the proposed survey of registered dieticians, nurse practitioners and pharmacists. Because while prior surveys of doctors and registered nurses that teased out exactly how many of those healthcare practitioners supplement themselves, and recommend that they’re patients do so as well, is important, more important will be measuring the response from this survey.
And that’s because this survey will actually measure the attitudes of those healthcare practitioners consumers see more often — the readily accessible pharmacist, nurse practitioner and, in those pharmacies that are actually fielding comprehensive programs (around diabetes, for example), registered nutritionists.
Drug Store News’ fearless prediction: like the doctors and registered nurses before them, many healthcare practitioners actively pursue healthier lifestyles, and that includes supplementing their diets with appropriate nutrients. And that means this group of practitioners will likewise supplement more often than not, and recommend their patients supplement as well in pursuit of a healthier lifestyle.
Conclusions drawn from this survey will have greater traction among suppliers and retailers in retail pharmacy, simply because this data will be more actionable. Based on CRN’s pending survey, suppliers and retailers will be better able to partner around comprehensive programs that tap into the expertise and enthusiasm healthcare professionals in the pharmacy setting have and exhibit concerning dietary supplements.